About PhotonPharma
PhotonPharma is a private company based in Fort Collins, Colorado. It has reported $3,257,821 raised in two offerings on Form D since March 2022. Its chief executive is Alan Rudolph.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 7, 2024 | May 22, 2024 | $349,998of $2.5M target | 2 | $174K | EquityRule 506(b) | Form D ↗ |
| Jan 31, 2022 | Mar 16, 2022amended Aug 29, 2023 | $2,907,823of $3.9M target | 8 | $363K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Total, two offerings | $3,257,821 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on PhotonPharma's Form D filed May 22, 2024.
TO
Terry Opgenorth
Director
WB
Wolfgang Baiker
Director
GG
Gary Gordon
Director
RG
Raymond Goodrich
Director
AR
Alan Rudolph
Chief Executive Officer and director
Earlier filings also listed Milton Chang (director, last listed Aug 2023).